Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Apolipoprotein epsilon4 advances appearance of psychosis in patients with Parkinson's disease.

Acta neurologica Scandinavica - 1 Jan 2006

Feldman B, Chapman J, Korczyn A D

Abstract excerpt

BACKGROUND: Psychosis is one of the most serious complications of advanced parkinsonism, but many patients are spared. The genetic factors predisposing to psychosis are unclear. OBJECTIVES: To assess the association between apolipoprotein E (APOE) polymorphism and the development of psychosis in patients with Parkinson's disease (PD). METHODS: Eighty-seven patients with advanced PD were assessed. Psychosis was...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Age of Onset
Share to Apolipoprotein E4
Share to Apolipoproteins E

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to APOE gene

Share to Genetic Predisposition to Disease

Share to Parkinson Disease

Share to Proportional Hazards Models

Share to Risk Factors

Source

Identifiers

PMID: 16367893
DOI: 10.1111/j.1600-0404.2005.00535.x

Genes

APOE

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Apolipoprotein epsilon4 advances appearance of psychosis in patients with Parkinson's disease.PMID 16367893Read ↗

The apolipoprotein E epsilon 4 allele increases the risk of drug-induced hallucinations in Parkinson's disease.Semantic proximity Read ↗

Presence of an APOE4 allele results in significantly earlier onset of Parkinson's disease and a higher risk with dementia.Semantic proximity Read ↗

Apolipoprotein E epsilon4 allele increases risk for psychotic symptoms in Alzheimer's disease.Semantic proximity Read ↗

Frequency of the apolipoprotein E epsilon 4 allele in a case-control study of early onset Parkinson's disease.Semantic proximity Read ↗

ApoE epsilon4 allele is associated with incidental hallucinations and delusions in patients with AD.Semantic proximity Read ↗

Association Between Psychosis Phenotype and APOE Genotype on the Clinical Profiles of Alzheimer's Disease.Semantic proximity Read ↗

Apolipoprotein E and alpha-1-antichymotrypsin genotypes do not predict time to psychosis in Alzheimer's disease.Semantic proximity Read ↗

Apolipoprotein E epsilon4 and catechol-O-methyltransferase alleles in autopsy-proven Parkinson's disease: relationship to dementia and hallucinations.Semantic proximity Read ↗

Late-life onset psychotic symptoms and incident cognitive impairment in people without dementia: modification by genetic risk for Alzheimer’s diseaseSemantic proximity Read ↗

Modulation of the age at onset of Parkinson's disease by apolipoprotein E genotypes.Semantic proximity Read ↗

Apolipoprotein-E (APO-E) genotype and symptoms of psychosis in Alzheimer's disease.Semantic proximity Read ↗

Delusion symptoms are associated with ApoE epsilon4 allelic variant at the early stage of Alzheimer's disease with late onset.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.